Doxofylline

규격

69975-86-6CAS 번호

274-239-6EC 번호

7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dioneIUPAC 명칭

C11H14N4O4화학식

266.25 g/mol분자량

DOXOFYLLINE; 69975-86-6; Doxophylline; Dioxyfilline; Ansimar; Ventax; Doxofilina; Doxofyllinum; Synasma; ABC 12/3; 7-(1,3-Dioxolan-2-ylmethyl)theophylline; DTXSID7022968; ABC-12/3; MPM23GMO7Z; NSC-759645; CHEBI:94714; 1H-Purine-2,6-dione, 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-; DTXCID002968; TMDO; 7-[(1,3-dioxolan-2-yl)methyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; doxofillina; 2-(7'-theophyllinemethyl)1,3-dioxolane; 7-((1,3-dioxolan-2-yl)methyl)-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; RefChem:590414; R03DA11; 274-239-6; Maxivent; 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione; MFCD00865218; 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione; 7-((1,3-dioxolan-2-yl)methyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione; NCGC00159330-02; 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-purine-2,6-dione; 7-((1,3-dioxolan-2-yl)methyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-1H-purine-2,6-dione; Doxofylline [USAN:INN]; Doxofilina [INN-Spanish]; Doxofyllinum [INN-Latin]; CAS-69975-86-6; SR-01000789760; EINECS 274-239-6; UNII-MPM23GMO7Z; BRN 0561195; 2-(7'-Theophyllinemethyl)-1,3-dioxolane; Ansimar;; 7-[(1,3-Dioxolan-2-yl)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; Maxivent (TN); 2-(7'-Teofillinmetil)-1,3-diossolano [Italian]; 7UH; DO-309; 2-(7'-Teofillinmetil)-1,3-diossolano; Doxofylline (Standard); DOXOFYLLINE [MI]; DOXOFYLLINE [INN]; Doxofylline (USAN/INN); DOXOFYLLINE [USAN]; Theophylline, 7-(1,3-dioxolan-2-ylmethyl)-; Epitope ID:613426; 1H-Purine-2,6-dione, 3,7-dihydro-7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-; 7-(1,3-Dioxolon-2-ylmethyl)-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-purindion; DOXOFYLLINE [MART.]; SCHEMBL37963; DOXOFYLLINE [WHO-DD]; 5-26-14-00120 (Beilstein Handbook Reference); MLS001214637; orb1224198; orb1310571; orb2300187; orb3141377; CHEMBL1527608; Doxofylline - Bio-X trade mark; Doxofylline, >=98% (HPLC); HY-B0004R; TMID-0118; HMS2090E04; HMS2877P10; HMS3652H03; HMS3714M21; HMS3885B09; HMS5082M22; Pharmakon1600-01502358; ABC-1213; HY-B0004; MSK10637; Tox21 111577; Tox21_111577; BBL012263; NSC759645; s4164; STK735429; AKOS005535592; Tox21_111577_1; AC-3492; CCG-213050; CS-8019; DB09273; DS-7424; FD65012; NSC 759645; NCGC00159330-03; NCGC00159330-04; NCGC00159330-09; NCGC00159330-10; BD164389; SMR000543614; SY053230; D4302; NS00036989; SW199176-2; D03898; D90272; AB00828111-06; AB00828111_07; AB00828111_08; F462728; L001990; Q425887; 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylxanthine; SR-01000789760-2; SR-01000789760-3; BRD-K70507123-001-08-9; BRD-K70507123-001-09-7동의어